The Role of Cytokeratin 19 in the Differential Diagnosis of True Papillary Carcinoma of Thyroid and Papillary Carcinoma-like Changes in Graves' Disease
Authors:
- 1 January 2005
- journal article
- Published by Springer Nature in Endocrine Pathology
- Vol. 16 (1) , 063-066
Abstract
Graves’ disease is an autoimmune disease predominantly seen in females. All types of thyroid cancers may co-exist with Graves’ disease but papillary carcinoma is the most frequent. Vesicular nuclei,...Keywords
This publication has 11 references indexed in Scilit:
- Distinction Between Papillary Thyroid Hyperplasia and Papillary Thyroid Carcinoma by Immunohistochemical Staining for Cytokeratin 19, Galectin-3, and HBME-1Endocrine Pathology, 2003
- Diagnostic Utility of Cytokeratin 19 Expression in Multinodular Goiter with Papillary Areas and Papillary Carcinoma of ThyroidEndocrine Pathology, 2002
- Cytokeratin 19 Immunoreactivity in the Diagnosis of Papillary Thyroid CarcinomaAmerican Journal of Clinical Pathology, 2001
- Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinomaHuman Pathology, 2000
- Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: Implications in tumor diagnosisHuman Pathology, 2000
- Utility of immunohistochemistry in the evaluation of necrotic thyroid tumorsHuman Pathology, 1999
- Differential expression of cytokeratins in follicular variant of papillary carcinoma: An immunohistochemical study and its diagnostic utilityHuman Pathology, 1999
- Hyperthyroïdie et cancer de la thyroïdeChirurgie, 1998
- Zytokeratinexpression benigner und maligner epithelialer SchilddrüsentumorenDer Pathologe, 1996
- Expression of Keratin 19 Distinguishes Papillary Thyroid Carcinoma from Follicular Carcinoma and Follicular Thyroid AdenomaAmerican Journal of Clinical Pathology, 1989